IMMUNOCARE Trademark

Trademark Overview

On Thursday, August 31, 2017, a trademark application was filed for IMMUNOCARE with the United States Patent and Trademark Office. The USPTO has given the IMMUNOCARE trademark a serial number of 87592117. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, June 8, 2020. This trademark is owned by Immunovative Therapies Ltd.. The IMMUNOCARE trademark is filed in the Medical & Beauty Services & Agricultural Services category with the following description:

Medical services for treatment of proliferative and metastatic diseases, namely, cancer
immunocare

General Information

Serial Number87592117
Word MarkIMMUNOCARE
Filing DateThursday, August 31, 2017
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, June 8, 2020
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, July 31, 2018

Trademark Statements

Goods and ServicesMedical services for treatment of proliferative and metastatic diseases, namely, cancer

Classification Information

International Class044 - Medical services; veterinary services; hygienic and beauty care for human beings or animals; agriculture, horticulture and forestry services.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateFriday, September 8, 2017
Primary Code044
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameImmunovative Therapies Ltd.
Party Type20 - Owner at Publication
Legal Entity Type99 - Other
AddressJerusalem 96951
IL
Party NameImmunovative Therapies Ltd.
Party Type10 - Original Applicant
Legal Entity Type99 - Other
AddressJerusalem 96951
IL

Trademark Events

Event DateEvent Description
Monday, June 8, 2020ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
Monday, June 8, 2020ABANDONMENT - NO USE STATEMENT FILED
Monday, January 20, 2020TEAS CHANGE OF CORRESPONDENCE RECEIVED
Friday, September 27, 2019NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, September 25, 2019EXTENSION 2 GRANTED
Wednesday, September 25, 2019EXTENSION 2 FILED
Wednesday, September 25, 2019TEAS EXTENSION RECEIVED
Thursday, March 21, 2019NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, March 19, 2019EXTENSION 1 GRANTED
Tuesday, March 19, 2019EXTENSION 1 FILED
Tuesday, March 19, 2019TEAS EXTENSION RECEIVED
Tuesday, September 25, 2018NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, July 31, 2018OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, July 31, 2018PUBLISHED FOR OPPOSITION
Wednesday, July 11, 2018NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Thursday, June 28, 2018APPROVED FOR PUB - PRINCIPAL REGISTER
Thursday, June 28, 2018EXAMINER'S AMENDMENT ENTERED
Thursday, June 28, 2018NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Thursday, June 28, 2018EXAMINERS AMENDMENT E-MAILED
Thursday, June 28, 2018EXAMINERS AMENDMENT -WRITTEN
Thursday, June 21, 2018TEAS/EMAIL CORRESPONDENCE ENTERED
Thursday, June 21, 2018CORRESPONDENCE RECEIVED IN LAW OFFICE
Tuesday, June 19, 2018ASSIGNED TO LIE
Wednesday, June 6, 2018TEAS RESPONSE TO OFFICE ACTION RECEIVED
Wednesday, December 6, 2017NOTIFICATION OF PRIORITY ACTION E-MAILED
Wednesday, December 6, 2017PRIORITY ACTION E-MAILED
Wednesday, December 6, 2017PRIORITY ACTION WRITTEN
Wednesday, December 6, 2017ASSIGNED TO EXAMINER
Friday, September 8, 2017NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Monday, September 4, 2017NEW APPLICATION ENTERED IN TRAM

Related Keywords

immunocare diseases namely cancer metastatic proliferative services treatment medical